Company intelligence / Profile preview

Sarsia Seed

Bergen, Vestland, Norway

Ownership: Private
Development stage: Other

Overview

Sarsia Seed is a Norwegian seed capital fund focused on early-phase technology companies in biotechnology, life sciences, and cleantech sectors. Established in 2006, it is the only specialized seed fund in Norway focused on life sciences, investing 1-5 million NOK for 10-40% ownership in seed-stage companies.

Industry: Investors

Partnerships

Co-investor relationships with industry partnersCo-investor relationships with other venture capital firms

Beyond the preview

Go deeper on Sarsia Seed.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sarsia Seed.

Explore the full profile